Analytical Data
-
Gene name
PTI
- Application
-
Alternative Names
SERPINB6; CAP; PI6; SPI3; Serpin Peptidase Inhibitor Clade B Member 6; Cytoplasmic antiproteinase; Peptidase inhibitor 6
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P35237
-
Expression Region
Met1~Pro376
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PTI (Protein Transformation Indicator) recombinant proteins have garnered significant interest in the field of biotechnology and molecular biology due to their potential applications in various research and therapeutic areas. The study of PTI proteins is rooted in the need for understanding protein interactions and functions within cellular processes. These proteins are often engineered to enhance stability, improve solubility, and facilitate easier purification, making them valuable tools in basic research and drug development. Advances in recombinant DNA technology have enabled the expression of PTI proteins in various host systems, allowing for large-scale production essential for functional studies. The application of PTI proteins extends to the development of biosensors, diagnostic tools, and therapeutic agents, particularly in the context of targeting specific diseases, including cancers and infectious diseases. Furthermore, understanding the structural and functional properties of PTI proteins can provide insights into their mechanisms of action, potentially leading to innovative strategies for intervention and treatment. Overall, the research on PTI recombinant proteins reflects a growing trend towards utilizing engineered proteins to address complex biological questions and to develop novel biomedical applications.
